Catherine Spiller, MD
Pediatrics · Walker, LANPI 1033131040
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 511 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 511 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- Lilly USA, LLC$756
- Pfizer$751
- Boehringer Ingelheim$497
- Merck$376
- plus $4K from 36 others
What the payments were for
- Food & beverage$8,276100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,276 in reported general payments places this provider in the 95th percentile of 913 pediatrics providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 133 | $170,024 |
| MounjaroTirzepatide | 84 | $135,376 |
| JardianceEmpagliflozin | 102 | $107,721 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 63 | $62,766 |
| FarxigaDapagliflozin Propanediol | 42 | $41,938 |
| XareltoRivaroxaban | 53 | $40,910 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 23 | $29,782 |
| EliquisApixaban | 13 | $19,065 |
| JanuviaSitagliptin Phosphate | 15 | $18,768 |
| Repatha SureclickEvolocumab | 13 | $15,899 |
| LinzessLinaclotide | 13 | $15,658 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 23 | $13,374 |
| NexlizetBempedoic Acid/Ezetimibe | 13 | $7,080 |
| MovantikNaloxegol Oxalate | 15 | $5,714 |
| Atorvastatin Calcium | 460 | $4,217 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,018 | $170,024133 claims |
| Lilly USA, LLCMounjaro | $756 | $135,37684 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $497 | $121,095125 claims |
| GSKTrelegy Ellipta | $373 | $62,76663 claims |
| AstraZenecaFarxiga | $374 | $41,93842 claims |
| Johnson & JohnsonXarelto | $137 | $40,91053 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $278 | $29,78223 claims |
| PfizerEliquis | $751 | $19,06513 claims |
| MerckJanuvia | $376 | $18,76815 claims |
| AbbVieLinzess, Synthroid | $1,066 | $17,88849 claims |
| Esperion Therapeutics, Inc.Nexlizet | $57 | $7,08013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 913 pediatrics providers in Louisiana.
Other pediatrics in Walker
- Corey HebertGretna$1.3M
- Katie QueenBogalusa$61K
- Elizabeth WhiteCovington$19K
- Neslihan GungorShreveport$16K
- Amy VitteLafayette$10K
- Alicia NicklasLafayette$9K
- Paul YuratichNew Orleans$9K
- Mamatha MandavaShreveport$8K
- Caroline KlineBaton Rouge$8K
- Sherri CaseyCovington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.